Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001835701-22-000002
Filing Date
2022-08-15
Accepted
2022-08-15 16:30:11
Documents
1
Effectiveness Date
2022-08-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9623
  Complete submission text file 0001835701-22-000002.txt   10632
Mailing Address 161 HODGE ROAD PRINCETON NJ 08540
Business Address 161 HODGE ROAD PRINCETON NJ 08540 609-325-7701
Enalare Therapeutics Inc. (Filer) CIK: 0001835701 (see all company filings)

EIN.: 853032063 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-456016 | Film No.: 221166038